Tweets
Population survey study of 933 gout pts (mean 58 yrs, 76% male,80% white) found total gout flare burden = 6.6 gout flares per year. Nearly 72% of gout flares were not reported, pretreated or prevented. Those less likely to report flares were young, less school, lower CCI, less… https://t.co/Z7KWk1YEFH https://t.co/0jDGNMOKjj
Dr. John Cush @RheumNow ( View Tweet )
3 hours 28 minutes ago
🎉 RheumNow Live 2025 is just about 2 weeks away! 🌟 Don't miss expert talks, interactive panels, networking, and the Karaoke Gong Show! Early registration extended—secure your spot now! 🗓️ Virtual & in-person options available.
https://t.co/EPZJMOGgNk https://t.co/cMoOTlWKYu
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 hours 28 minutes ago
Fallen Angels (1.17.2025)
Dr. Jack Cush reviews the news and journal reports from the past week on https://t.co/V10S4oVFsv; and pays homage to colleagues who passed away in 2024.
https://t.co/1DvtGbUHEk https://t.co/EnZ8D6xzgk
Dr. John Cush @RheumNow ( View Tweet )
7 hours 27 minutes ago
post hoc analysis of 4 registration trials of pegloticase, show rates of MACE and Thromboembolic Events were Infrequent (<1.5%; 35.4 events/1000 PY), similar to general gout population (31.7 events/1000 person-years) https://t.co/z1QAELA3ua https://t.co/polmf9hI6I
Dr. John Cush @RheumNow ( View Tweet )
9 hours 28 minutes ago
We must learn to live together as brothers or perish together as fools.
Martin Luther King Jr. (1929 - 1968) https://t.co/3mWHhPY5rH
Dr. John Cush @RheumNow ( View Tweet )
11 hours ago
Medicare has announced another 15 expensive drugs (now total 25) undergoing price negotiation with manufacturers. Enbrel and Stelara were in the 1st ten. Included in the next 15 Rx are Ofev (nintenib) & Otezla (apremilast) & GLP-1 drugs. https://t.co/SBwSprvo6K… https://t.co/okJXJCgOFm https://t.co/im2ggtgvt3
Dr. John Cush @RheumNow ( View Tweet )
11 hours 58 minutes ago
FDA has sent a Drug Safety Letter to VETERINARIANS about the use of Librela (bedinvetmab) & reported adverse reactions, deaths and neurological problems (ataxia, seizures, paresis). Rx was approved 5/23 to treat pain from osteoarthritis in dogs. https://t.co/LIZ4ZzXtmk https://t.co/uOVc2xsD5g
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Study of predominantly older males from the Veterans Health Administration (VHA) data, shows the use of b/ts-DMARDs is not associated with a risk for multiple myeloma. From 27,540 RA pts, 30% took b/tsDMARD, 77 incident MM (HR1.32;95% CI 0.78, 2.26) https://t.co/KZLEfq8vRK https://t.co/7qLQISRCoC
Dr. John Cush @RheumNow ( View Tweet )
1 day 5 hours ago
"I'd rather be a failure at something I love than a success at something I hate."
- Martin Luther King Jr. https://t.co/E2f5mEV9Jx
Dr. John Cush @RheumNow ( View Tweet )
1 day 6 hours ago
QD Clinic - Natural RA
PsO/PsA patient avoiding DMARDs and Biologics, and wants Natural therapies
Features Dr. Jack Cush
QD Clinics - lessons from the clinic, sponsored by RNL2025 in Dallas, TX; Feb 8 & 9, 2025
Register at https://t.co/2dcFVgu8z6
https://t.co/nYhcPaC0qW https://t.co/wT80JoY4OE
Dr. John Cush @RheumNow ( View Tweet )
1 day 7 hours ago
Childhood Maltreatment and the Risk of Rheumatic Diseases
A UK retrospective matched open cohort study shows that children who suffered from abuse, neglect or domestic abuse carry a significantly increased risk of developing rheumatoid arthritis or psoriasis in later life.… https://t.co/f0XMDJbvvg https://t.co/9KvpixsNFL
Dr. John Cush @RheumNow ( View Tweet )
1 day 9 hours ago
Outcomes of Multisystem Inflammatory Syndrome in Children (MIS-C)
A nationwide cohort study of patients with MIS-C, a life-threatening complication of COVID-19 infection, showed that many had severe disease during the acute phase, but most recovered quickly and had a reassuring… https://t.co/qbV4Z8SX0x https://t.co/VUD5KHeXZH
Dr. John Cush @RheumNow ( View Tweet )
1 day 11 hours ago